Back to Search Start Over

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Authors :
Bar, Jair
Peled, Nir
Schokrpur, Shiruyeh
Wolner, Mirjana
Rotem, Ofer
Girard, Nicolas
Aboubakar Nana, Frank
Derijcke, Sofie
Kian, Waleed
Patel, Sandip
Gantz-Sorotsky, Hadas
Zer, Alona
Moskovitz, Mor
Metro, Giulio
Rottenberg, Yakir
Calles, Antonio
Hochmair, Maximilian
Cuppens, Kristof
Decoster, Lynn
Reck, Martin
Limon, Dror
Rodriguez, Estelamari
Astaras, Christoforos
Bettini, Adrienne
Häfliger, Simon
Addeo, Alfredo
Source :
Journal of Thoracic Oncology; February 2023, Vol. 18 Issue: 2 p169-180, 12p
Publication Year :
2023

Abstract

Approximately 10% of EGFR mutations (EGFRmuts) are uncommon (ucEGFRmuts). We aimed to collect real-world data about osimertinib for patients with ucEGFRmuts.

Details

Language :
English
ISSN :
15560864 and 15561380
Volume :
18
Issue :
2
Database :
Supplemental Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Periodical
Accession number :
ejs61724009
Full Text :
https://doi.org/10.1016/j.jtho.2022.10.004